DeLorey T M, Kissin I, Brown P, Brown G B
Department of Chemistry, University of Alabama, Birmingham.
Anesth Analg. 1993 Sep;77(3):598-605. doi: 10.1213/00000539-199309000-00030.
Combinations of benzodiazepines (midazolam and diazepam) with barbiturates (pentobarbital and phenobarbital) exhibit synergistic (supra-additive) hypnotic interactions in rats. Because both benzodiazepines and barbiturates interact with the gamma-aminobutyric acidA (GABAA) receptor complex, we have tested the hypothesis that these supra-additive hypnotic interactions are due to a synergistic effect on Cl- conductance subsequent to binding at allosterically coupled sites on the GABAA receptor ionophore complex. Equilibrium binding and 36Cl- flux measurements were performed under nearly identical conditions using rat brain cerebrocortical synaptoneurosomes. The benzodiazepines and barbiturates alone both allosterically enhance binding of [3H]muscimol to comparable, but modest, extents (range = 18%-32% enhancement). Isobolographic analysis reveals that combinations of benzodiazepines and barbiturates do in fact produce a synergistic enhancement of [3H]muscimol binding. Paradoxically, this effect is not translated into a synergistic enhancement of muscimol-stimulated 36Cl- flux. Because the positively cooperative interactions between benzodiazepines and barbiturates, as demonstrated both behaviorally and by binding measurements, are not reflected in enhanced Cl- conductance, the mechanistic basis for hypnotic synergism may involve other non-GABAergic components.
苯二氮䓬类药物(咪达唑仑和地西泮)与巴比妥类药物(戊巴比妥和苯巴比妥)联合使用时,在大鼠中表现出协同(超相加)催眠相互作用。由于苯二氮䓬类药物和巴比妥类药物均与γ-氨基丁酸A(GABAA)受体复合物相互作用,我们检验了以下假设:这些超相加催眠相互作用是由于在GABAA受体离子载体复合物上的变构偶联位点结合后对氯离子电导产生协同效应所致。使用大鼠脑皮质突触神经小体在几乎相同的条件下进行平衡结合和36Cl-通量测量。单独使用苯二氮䓬类药物和巴比妥类药物均能变构增强[3H]蝇蕈醇的结合,但程度相当且适中(增强范围为18%-32%)。等效线图分析表明,苯二氮䓬类药物和巴比妥类药物的组合实际上确实能协同增强[3H]蝇蕈醇的结合。矛盾的是,这种效应并未转化为蝇蕈醇刺激的36Cl-通量的协同增强。由于苯二氮䓬类药物和巴比妥类药物之间的正协同相互作用,无论是行为学上还是结合测量中都已得到证明,但并未反映在增强的氯离子电导上,催眠协同作用的机制基础可能涉及其他非GABA能成分。